Access in all areas? A round up of developments in market access and health technology assessment: part 8
In this update, we discuss the pricing paradox of combination therapies in health technology assessment; examine the Inflation Reduction Act’s impact on pharmaceutical innovation and analyze the revised Dutch economic evaluation guidelines.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2025-01-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|